A new WHO report reviews progress and challenges in the global response to HIV, tuberculosis, malaria, hepatitis and neglected tropical diseases against the Millennium Development Goals, and identifies the strategies and approaches needed to accelerate progress during the new development era.

WHO consolidated guidelines: Integrating collaborative TB and HIV services within a comprehensive package of care for people who inject drugs

The work plan template is intended to guide the implementation of Xpert MTB/RIF testing in facilities providing clinical services.

As planning for U.S. government spending in fiscal year (FY) 2017 is underway, advocates from U.S.-based NGOs and civil society groups have appealed to legislators to prioritize TB.

Universities Allied for Essential Medicines (UAEM) launches Re:Route, a mapping of alternative biomedical research and development (R&D) initiatives.

Stop TB Partnership launches World TB Day webpage and social media campaign.

The study explores how to separate the costs of research and development (R&D) from the future market price of vaccines, medicines and diagnostics – a concept known as “delinkage”.

The initiative will allow countries to access delamanid through the Stop TB Partnership’s Global Drug Facility at a price of US$ 1700 for each full-course treatment of six months’ duration.

The theme of this year's World TB Day will be "Unite to End TB"! Campaign materials are now available in 6 languages.

The theme for the 2016 Kochon Prize, for the second year, will be “Unsung Heroes Working to End TB: Episode 2.”